Lorraine L. Rosamilia, MD
Dr. Rosamilia is from the Department of Dermatology, Geisinger Health System, State College, Pennsylvania.
Dr. Rosamilia reports no conflicts of interest in relation to this post.
JAMA Dermatology recently published a case-control study from the University of Pittsburgh wherein 4 smartphone applications (apps) designed to aid consumers in determining if a skin lesion is benign or malignant were put to the test. Digital images taken by dermatologists of 60 melanomas and 128 benign control lesions (prior to skin biopsy and dermatopathologist-determined diagnosis) were uploaded into these consumer apps, and there was a very broad range of diagnostic sensitivity and specificity. [More]